EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Elderly‐Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns

Maya Granot iD, Uri Kopylov iD, Yael Talmor, Nurit Nachum, Alexander Krauthammer iD, Tal Berger, Chaya Mushka Abitbol, Arad Dotan, Elhanan Borenstein, Shomron Ben-Horin iD, Batia Weiss, Yael Haberman

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70092 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Maya Granot und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology and Nutrition, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Crohn Disease, Colitis, Ulcerative, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Culture and Sport, Crohn`s Colitis Foundation LITWIN IBD pioneer award, Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Elderly‐onset inflammatory bowel disease (IBD) patients (age ≥ 60 at diagnosis) have unique characteristics that require special consideration. Using a real‐life registry‐based cohort, we compared disease phenotypes and treatment exposures between adult‐onset (18 ≤ age < 60 years) and elderly‐onset IBD patients.

Methods

Demographics, disease characteristics, and treatment were compared between adult‐ and elderly‐onset IBD patients diagnosed during 2000–2022 with ≥ 12 months follow‐up.

Results

Of 3307 adult IBD patients, 290 (9%) were elderly‐onset. This group exhibited a higher prevalence of colon‐only involvement, with higher rates of ulcerative colitis (UC, 38.3% vs. 31.4%, p = 0.02) and more colonic L2 Crohn's Disease (CD, 21% vs. 12%, p < 0.001) then adult‐onset group. Elderly‐onset CD also showed less ileocolonic L3 disease (14% vs. 29%, p < 0.001), less penetrating B3 phenotype (7.4% vs. 19%, p < 0.001), and less perianal involvement (10% vs. 20%, p < 0.001). Elderly‐onset CD and UC patients received more 5‐ASA (36% vs. 17%, p < 0.001 in CD and 75% vs. 63%, p = 0.02 in UC). In contrast, these patients were exposed to considerably less biologics and/or JAK inhibitors (37% vs. 56% for CD and 20% vs. 35% for UC, p < 0.001), with higher 15‐year biologic‐free survival among elderly‐onset IBD. First‐line biological choices also substantially differed, with adult‐onset receiving more anti‐TNFs and elderly‐onset receiving more Vedolizumab. We did not observe higher rates of IBD‐related surgeries and steroid use between the groups.

Conclusions

Elderly‐onset IBD shows higher prevalences of colon‐only IBD (UC and L2 CD). Treatment strategies in elderly‐onset IBD favor 5‐ASA and show reduced biological use, with preferences for Vedolizumab over anti‐TNFs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseColitis, UlcerativeInflammatory Bowel DiseasesHumansMaleFemaleMiddle AgedAdultAge of OnsetRegistriesAgedPhenotypeYoung AdultAdolescentAge FactorsPrevalence

Stichwörter der Autor:innen

5‐ASACrohn's diseaseVedolizumabanti‐TNFsbiologicselderly‐onsetinflammatory bowel diseasetreatment patternsulcerative colitis

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology and Nutrition, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
  • School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
  • Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel.
  • Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel.
  • Santa Fe Institute, Santa Fe, New Mexico, USA.
  • Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Maya Granot, Uri Kopylov, Alexander Krauthammer, Shomron Ben-Horin

Förderung

  • Ministry of Culture and Sport
  • Crohn`s Colitis Foundation LITWIN IBD pioneer award
  • Israel Science Foundation
  • Leona M. and Harry B. Helmsley Charitable Trust
  • Colton Center for Autoimmunity
  • European Research Council

Zitieren

APA

Granot, M., Kopylov, U., Talmor, Y., Nachum, N., Krauthammer, A., Berger, T., Abitbol, C. M., Dotan, A., Borenstein, E., Ben-Horin, S., Weiss, B., & Haberman, Y. (2025). Elderly‐Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70092

Vancouver

Granot M, Kopylov U, Talmor Y, Nachum N, Krauthammer A, Berger T, et al. Elderly‐Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70092

BibTeX
@article{Granot2025,
  author = {Granot, Maya and Kopylov, Uri and Talmor, Yael and Nachum, Nurit and Krauthammer, Alexander and Berger, Tal and Abitbol, Chaya Mushka and Dotan, Arad and Borenstein, Elhanan and Ben-Horin, Shomron and Weiss, Batia and Haberman, Yael},
  title = {Elderly‐Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70092}
}
Kostenlos starten →